Table 1.
Other cell-derived exosomes act on B cells | ||||||
---|---|---|---|---|---|---|
Tumor type | Source | In vivo/in vitro | Action type/specific axis | Effect | Effects on tumors | Ref. |
—— | DC | In vivo | Stimulate B cell proliferation | CD8 + T cell response was induced | Kill cancer cells | (68) |
—— | Mature DC | In vivo | Binds to B cell receptors | Induces T cell proliferation | —— | (69) |
—— | T cells | In vivo | —— | Promote B cell proliferation and differentiation | —— | (70) |
—— | Mesenchymal cells | —— | TGF-β1 is produced | Regulates B cell proliferation and survival | —— | (71) |
HCC | Tumor cells | In vitro | HMGB1-TLR2/4-MAPK | Induction of B cells to become TIM-1Breg, impairing CD 8T cell function | Promote HCC progression | (72) |
HNSCC | plasma | In vitro | —— | Inhibits the proliferation, viability and function of B cells | Helps immune escape | (73) |
B-cell-derived exosomes act on other cells | ||||||
Tumor type | Target cells | In vivo/in vitro | Action type/specific axis | Effect | Effects on tumors | Ref. |
Ovarian cancer | cancer cell | In vitro | miR-330-3p/JAM2 axis | Inducing mesenchymal procedures | Promote the growth of cancer cells | (74) |
—— | T cell | In vivo | Rab27a expression is up-regulated | Impaired CD8T cell response | Promote tumor survival | (75) |
—— | T cell | In vivo | C3 fragments are deposited on the surface of the cell membrane | Enhance T cell response, conducive to the development of immune response | Inhibits tumors | (76) |
—— | Macrophages | In vivo | Enhances lipopolysaccharide stimulation | Reduces the release of TNFα | Promote tumor survival | (77) |